A post-hoc analysis of the phase 3b JUMP trial assessed outcomes in patients with myelofibrosis and baseline anemia who were treated with ruxolitinib alongside anemia-supportive therapies, according ...

Dear I.F.: The DV (a replacement for what we used to call the recommended daily allowance, or RDA) for vitamin B12 is 2.4 mcg ...

Targeted therapies and immunotherapy can provide benefits when added to chemotherapy or may eliminate the need for ...

It’s important for clinicians to assess patients undergoing percutaneous coronary intervention (PCI) for both anemia and chronic kidney disease (CKD).

During a live event, Thomas LeBlanc, MD, MA, discussed the outcomes of the COMMANDS trial of luspatercept in myelodysplastic ...

A recent trial reveals that nivolumab combined with chemotherapy significantly improves survival rates in older patients with ...

Liberal blood transfusion after heart attack in patients with kidney disease (CKD) is not harmful, according to study results.

Lupus can be debilitating and sometimes deadly for the 3 million people who have it. A treatment called CAR T appears to stop ...

Cohen, E. and Kubinak, N. (2025) A Rare Presentation of Cavernous Sinus Thrombosis in a Young Female. Surgical Science, 16, ...

A local foreign-language teacher dealt with a debilitating condition that required blood transfusions for years before finally getting a life-saving transplant in Orlando. Now, she’s sharing her ...

Over a hundred sickle cell warriors and their families turned out in support for World Sickle Cell Day at West Oakland’s ...

Researchers have found a strong correlation between vascular access status (VAS) and demoralization syndrome (DS) in elderly ...